ZBH Zimmer Biomet Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZBH

Price (delayed)

$99.57

Market cap

$18.99B

P/E Ratio

24.11

Dividend/share

$0.96

EPS

$4.13

Enterprise value

$26.06B

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 51
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 63

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of ...

Highlights
The revenue has grown by 9% YoY
Zimmer Biomet Holdings's gross profit has increased by 7% YoY
ZBH's P/E is 49% lower than its 5-year quarterly average of 47.4 but 3% higher than its last 4 quarters average of 23.4
The net income has grown by 6% since the previous quarter but it has declined by 2% year-on-year
ZBH's quick ratio is down by 10% YoY and by 4% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zimmerbiomet.com
Peers: BSX COO SYK EW

Key stats

What are the main financial stats of ZBH

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
1.72%
1 week
2.45%
1 month
5.84%
1 year
-3.54%
YTD
10.73%
QTD
15.66%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$8.51B
Gross profit
$5.95B
Operating income
$1.21B
Net income
$806.6M
Gross margin
69.9%
Net margin
9.5%
Zimmer Biomet Holdings's operating margin has decreased by 12% YoY
The net margin has declined by 10% year-on-year but it has increased by 4.4% since the previous quarter
The revenue has grown by 9% YoY
Zimmer Biomet Holdings's gross profit has increased by 7% YoY

Price vs fundamentals

How does ZBH's price correlate with its fundamentals

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
ZBH P/E details
P/E
24.11
P/B
1.53
P/S
2.25
EV/EBIT
21.32
EV/EBITDA
11.18
EV/Sales
3.06
ZBH's P/E is 49% lower than its 5-year quarterly average of 47.4 but 3% higher than its last 4 quarters average of 23.4
The EPS has grown by 7% from the previous quarter
The stock's P/B is 19% below its 5-year quarterly average of 1.9 but 9% above its last 4 quarters average of 1.4
ZBH's price to sales (P/S) is 30% lower than its 5-year quarterly average of 3.2 but 2.3% higher than its last 4 quarters average of 2.2
The revenue has grown by 9% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROIC has decreased by 10% YoY but it has increased by 2.1% QoQ
The ROS has contracted by 8% YoY
Zimmer Biomet Holdings's return on equity has increased by 7% QoQ but it has decreased by 3% YoY
The ROA has grown by 6% from the previous quarter but it has contracted by 5% YoY

Dividends

What is ZBH's dividend history
Dividend details
DPS
$0.96
Dividend yield
0.96%
Payout ratio
23.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 124% higher than the total liabilities
ZBH's quick ratio is down by 10% YoY and by 4% QoQ
The current ratio has contracted by 10% YoY and by 2.3% from the previous quarter
The debt is 41% smaller than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.